BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3675083)

  • 1. Reversal by hypothermia of vasodilator-induced tachycardia in anesthetized rats.
    Vidrio H; García-Márquez F
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):217-28. PubMed ID: 3675083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the sympatho-adrenal system in the reflex tachycardia produced by hydralazine in the anesthetized rat.
    Vidrio H; García-Márquez F
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):94-104. PubMed ID: 3099672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cyclo-oxygenase inhibitors on the cardiovascular effects of hydralazine in rats.
    Vidrio H; Garcia-Marquez F
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):131-41. PubMed ID: 3923959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of heart rate responses to hydralazine in normotensive and hypertensive rats.
    Vidrio H
    Arch Med Res; 1996; 27(3):299-303. PubMed ID: 8854385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
    Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
    J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on bradycardia mechanism in the moderately hypothermic dog.
    Estima-Martins AM
    Rev Esp Fisiol; 1975 Dec; 31(4):277-82. PubMed ID: 1215620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
    Pettinger WA; Keeton K
    J Clin Invest; 1975 Feb; 55(2):236-43. PubMed ID: 236325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-tachycardiac effect of a direct-acting vasodilator, budralazine].
    Yoshioka M
    Hokkaido Igaku Zasshi; 1989 May; 64(3):255-68. PubMed ID: 2767613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hydralazine on adrenal and cardiac sympathetic nerve activity in anesthetized rats.
    Yoshioka M; Togashi H; Minami M; Saito H
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):313-20. PubMed ID: 3797810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of prazosin.
    Oates HF; Graham RM; Stoker LM; Stokes GS
    Arch Int Pharmacodyn Ther; 1976 Dec; 224(2):239-47. PubMed ID: 1015921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
    Savci V; Cavun S; Goktalay G; Ulus IH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the in vivo and in vitro cardiovascular effects of a hydralazine-like vasodilator agent (HPS-10) in normotensive rats.
    Orallo F
    Br J Pharmacol; 1997 Aug; 121(8):1627-36. PubMed ID: 9283696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of urethane on hydralazine-induced tachycardia in rats.
    Orallo F; Fontenla JA; Loza MI; Campos M; Calleja JM
    Gen Pharmacol; 1992 Nov; 23(6):1143-7. PubMed ID: 1487125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine potentiates vasodilator-induced renin release.
    Tofovic SP; Branch KR; Oliver RD; Magee WD; Jackson EK
    J Pharmacol Exp Ther; 1991 Mar; 256(3):850-60. PubMed ID: 2005584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of various vasodilator drugs using lower body negative pressure.
    de Metz JE; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1979 Apr; 238(2):268-82. PubMed ID: 475514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term pretreatment with isoproterenol on bromocriptine-induced tachycardia in conscious rats.
    Lahlou S; Lima GC; Leão-Filho CS; Duarte GP
    Can J Physiol Pharmacol; 2000 Mar; 78(3):260-5. PubMed ID: 10721819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine-induced tachycardia in conscious rats: blunted response following isoproterenol pretreatment for 5 days.
    Lahlou S; Duarte GP
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(3):165-74. PubMed ID: 9777039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.
    Shibamura S; Chiba T; Suzuki I; Akashi A
    Arzneimittelforschung; 1981; 31(7):1076-9. PubMed ID: 6268123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular actions of buflomedil and possible mechanisms involved.
    Kushiku K; Ohba M; Mikagi T; Nuki S; Araki Y; Furukawa T
    Arzneimittelforschung; 1989 Jun; 39(6):670-7. PubMed ID: 2775333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.